Showing results (1-10 of 353) with videos related to
Sort By:
Pageof 36
Statistics in Medicine|May 4, 2007
Tests of association under misclassification: application to histological sampling in oncologyRebecca A Betensky, David N Louis, J Gregory CairncrossJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Influence of unrecognized molecular heterogeneity on randomized clinical trialsRebecca A Betensky, David N Louis, J Gregory CairncrossBiostatistics (Oxford, England)|August 20, 2003
Analysis of a molecular genetic neuro-oncology study with partially biased selectionRebecca A Betensky, David N Louis, J Gregory CairncrossCancer Research|March 26, 2002
DMBT1 polymorphisms: relationship to malignant glioma tumorigenesisHikaru Sasaki, Rebecca A Betensky, J Gregory Cairncross, et al.Biometrics|March 14, 2002
The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and powerYi Li, Rebecca A Betensky, David N Louis, et al.Neuron Glia Biology|March 8, 2006
Neural development and the ontogeny of central nervous system tumorsScott L PomeroyCancer Research|April 3, 2003
Gene expression-based classification of malignant gliomas correlates better with survival than histological classificationCatherine L Nutt, D R Mani, Rebecca A Betensky, et al.Journal of Neuropathology and Experimental Neurology|February 7, 2002
Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma"Hikaru Sasaki, Magdalena C Zlatescu, Rebecca A Betensky, et al.Neurology|July 30, 2008
Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomasWarren P Mason, J Gregory CairncrossJournal of Neurosurgery|July 24, 2002
Acetazolamide therapy for symptomatic plateau waves in patients with brain tumors. Report of three casesChristopher J Watling, J Gregory CairncrossPageof 36